Cognizant (CTSH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Cognizant reported revenue of $5.25 billion for the quarter ended June 2025, reflecting an 8.1% increase year-over-year and surpassing the Zacks Consensus Estimate of $5.19 billion by 1.01% [1] - Earnings per share (EPS) for the quarter was $1.31, up from $1.17 in the same quarter last year, exceeding the consensus EPS estimate of $1.26 by 3.97% [1] Revenue Performance by Segment - Health Sciences revenue was $1.55 billion, slightly below the average estimate of $1.61 billion, representing a year-over-year increase of 6.2% [4] - Communications, Media and Technology revenue reached $841 million, exceeding the average estimate of $826.36 million, with a year-over-year growth of 3.1% [4] - Products and Resources generated $1.31 billion, surpassing the estimated $1.25 billion, marking a significant year-over-year increase of 16% [4] - Financial Services revenue was $1.55 billion, slightly above the average estimate of $1.52 billion, reflecting a year-over-year growth of 6.9% [4] Stock Performance - Cognizant's shares have declined by 6.9% over the past month, contrasting with the Zacks S&P 500 composite's increase of 3.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]